Transforming mental wellbeing through scientific innovation

A shadow pandemic of mental health disorders

The WHO estimate that 1 in 8 people globally live with a mental health condition. These conditions include depression, substance use disorder and post-traumatic stress disorder.

We do not accept the status quo.  

We envision a world where this burden is lifted.  

We seek to enhance mental well-being.

Pacalis: Latin. Adjective

Of or pertaining to peace, peaceful.

Pacalis Therapeutics Pty Ltd is a privately-held biotechnology company focused on the optimization and development of next-generation medicines for key classes of mental health disorders. 

Innovating new therapeutics to improve mental health

Harnessing its co-founders' expertise across pharmacology, neuroscience and drug discovery and development, Pacalis is developing first-in-class therapeutics for conditions such as Major Depressive Disorder (MDD), Substance Use Disorder (SUD) and Post-Traumatic Stress Disorder (PTSD).

The Experienced Team Driving Pacalis